ClariVest Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.8M | Hold |
43,911
| – | – | 0.29% | 82 |
|
|
2024
Q2 | $2.8M | Sell |
43,911
-6,199
| -12% | -$395K | 0.29% | 82 |
|
|
2024
Q1 | $3.46M | Sell |
50,110
-71
| -0.1% | -$4.91K | 0.36% | 56 |
|
|
2023
Q4 | $2.77M | Sell |
50,181
-1,157
| -2% | -$63.8K | 0.15% | 103 |
|
|
2023
Q3 | $2.98M | Buy |
51,338
+13,792
| +37% | +$801K | 0.16% | 92 |
|
|
2023
Q2 | $2.02M | Buy |
+37,546
| New | +$2.02M | 0.1% | 130 |
|
|
2022
Q2 | – | Sell |
-18,643
| Closed | -$524K | – | 687 |
|
|
2022
Q1 | $524K | Sell |
18,643
-2,953
| -14% | -$83K | 0.02% | 379 |
|
|
2021
Q4 | $995K | Buy |
21,596
+21,553
| +50,123% | +$993K | 0.03% | 319 |
|
|
2021
Q3 | $1K | Buy |
+43
| New | +$1K | ﹤0.01% | 662 |
|
|
2015
Q2 | – | Sell |
-40,550
| Closed | -$2.54M | – | 605 |
|
|
2015
Q1 | $2.54M | Buy |
40,550
+2,026
| +5% | +$127K | 0.08% | 158 |
|
|
2014
Q4 | $2.17M | Sell |
38,524
-6,477
| -14% | -$365K | 0.08% | 150 |
|
|
2014
Q3 | $1.27M | Sell |
45,001
-35
| -0.1% | -$990 | 0.05% | 217 |
|
|
2014
Q2 | $1.55M | Sell |
45,036
-11,578
| -20% | -$399K | 0.06% | 200 |
|
|
2014
Q1 | $1.78M | Buy |
+56,614
| New | +$1.78M | 0.07% | 177 |
|